Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 13, 2023
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
Wed, April 12, 2023
[ Wed, Apr 12th 2023
] - WOPRAI
Mayank Mamtani Initiated (TRVI) at Strong Buy and Held Target at $6 on, Apr 12th, 2023
Mayank Mamtani of B. Riley Securities, Initiated "Trevi Therapeutics, Inc." (TRVI) at Strong Buy and Held Target at $6 on, Apr 12th, 2023.
Mayank has made no other calls on TRVI in the last 4 months.
There are 2 other peers that have a rating on TRVI. Out of the 2 peers that are also analyzing TRVI, 0 agree with Mayank's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Mayank
- Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $8 on, Friday, March 17th, 2023
- Sean Kim of "JonesTrading" Initiated at Strong Buy and Held Target at $7 on, Tuesday, March 14th, 2023
